http://rdf.ncbi.nlm.nih.gov/pubchem/patent/HK-1252579-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2d62277cd03acf7400f7588b16d189a9
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07F5-027
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-69
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07F5-025
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07F5-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07F5-04
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K-
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07F-
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P-
filingDate 2018-09-17-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3f6dd40e97d0c77f00fe07c1ea967301
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e19f9447b25245bd264dc05e0eed7564
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bff705a4940a5ae2832c0fdbd88b1e8d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4e30f64b0881b3eef1fdd7e78bc8df97
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9a95469be8e468ce85f0d22547f2e777
publicationDate 2019-05-31-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber HK-1252579-A1
titleOfInvention As a boron-based 4-hydroxytamoxifen and indoxifen prodrug for the treatment of breast cancer
priorityDate 2012-03-05-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419530773
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426154977
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID10090750
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5462311
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID449459
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559585

Total number of triples: 27.